Literature DB >> 19444297

Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?

T M Curtis1, T A Gardiner, A W Stitt.   

Abstract

Retinopathy is a major complication of diabetes mellitus and this condition remains a leading cause of blindness in the working population of developed countries. As diabetic retinopathy progresses a range of neuroglial and microvascular abnormalities develop although it remains unclear how these pathologies relate to each other and their net contribution to retinal damage. From a haemodynamic perspective, evidence suggests that there is an early reduction in retinal perfusion before the onset of diabetic retinopathy followed by a gradual increase in blood flow as the complication progresses. The functional reduction in retinal blood flow observed during early diabetic retinopathy may be additive or synergistic to pro-inflammatory changes, leucostasis and vaso-occlusion and thus be intimately linked to the progressive ischaemic hypoxia and increased blood flow associated with later stages of the disease. In the current review a unifying framework is presented that explains how arteriolar dysfunction and haemodynamic changes may contribute to late stage microvascular pathology and vision loss in human diabetic retinopathy.

Entities:  

Mesh:

Year:  2009        PMID: 19444297     DOI: 10.1038/eye.2009.108

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  114 in total

Review 1.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study.

Authors:  Line Pedersen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-01       Impact factor: 3.117

3.  Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus.

Authors:  Jae-Seung Yun; Seung-Hyun Ko; Ji-Hoon Kim; Keon-Woong Moon; Kun-Woong Moon; Yong-Moon Park; Ki-Dong Yoo; Yu-Bae Ahn
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

4.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

5.  Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes.

Authors:  Valli Velayutham; Paul Z Benitez-Aguirre; Maria E Craig; Gerald Liew; Tien Y Wong; Alicia J Jenkins; Kim C Donaghue
Journal:  Diabetologia       Date:  2017-07-15       Impact factor: 10.122

Review 6.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

7.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

8.  Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic rats.

Authors:  Sijiao Chen; Tao Yang; Furong Liu; Hongyan Li; Yinghua Guo; Hongyan Yang; Jinchun Xu; Jindan Song; Zhiming Zhu; Daoyan Liu
Journal:  Inflamm Res       Date:  2013-10-31       Impact factor: 4.575

Review 9.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

Review 10.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.